A brief overview of novel approaches to FDG PET imaging and quantification

被引:22
作者
Hess S. [1 ]
Blomberg B.A. [1 ,2 ]
Rakheja R. [3 ]
Friedman K. [3 ]
Kwee T.C. [2 ]
Høilund-Carlsen P.F. [1 ]
Alavi A. [4 ]
机构
[1] Department of Nuclear Medicine, Odense University Hospital, 5000 Odense
[2] Department of Radiology and Nuclear Medicine, University Medical Centre, Utrecht
[3] Nuclear Medicine Section, Department of Radiology, New York University School of Medicine, NY, NY
[4] Division of Nuclear Medicine, University of Pennsylvania Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
关键词
Molecular imaging; PET; PET/CT; Positron emission tomography; Quantification;
D O I
10.1007/s40336-014-0062-2
中图分类号
学科分类号
摘要
The widespread implementation of hybrid FDG PET/CT worldwide has brought about a paradigm shift in the use of diagnostic imaging-molecular imaging combining morphological and functional data is now at the forefront of patient management in many clinical settings, not only for initial diagnosis, staging, monitoring of response to treatment and detection of recurrence, but also for prognostication and disease characterization. Although developments have focused particularly on the qualitative visual analysis of images, FDG PET allows elaborate quantification, which should be explored much more in the future and ideally standardized worldwide. In this brief overview, we outline the state of the art of novel and quantitative approaches to FDG imaging, i.e. standard uptake value, partial volume effect and partial volume correction, multiple-time-point imaging, assessment of global disease burden and PET/MRI, all of which we expect to see evolving as powerful tools in the coming years and enhancing sensitivity and specificity in variety of clinical settings, in which FDG PET imaging has not yet shown its full potential. © 2014 Italian Association of Nuclear Medicine and Molecular Imaging.
引用
收藏
页码:187 / 198
页数:11
相关论文
共 54 条
[1]  
Mankoff D.A., A definition of molecular imaging, J Nucl Med, 48, 18 N, (2007)
[2]  
Hess S., Blomberg B.A., Zhu H., Hoilund-Carlsen P.F., Alavi A., The pivotal role of FDG-PET/CT in modern medicine, Acad Radiol, 21, pp. 232-249, (2014)
[3]  
Portnow L.H., Vaillancourt D.E., Okun M.S., The history of cerebral PET scanning. From physiology to cutting-edge technology, Neurology, 80, pp. 952-956, (2013)
[4]  
Hoilund-Carlsen P.F., Gerke O., Vilstrup M.H., Et al., PET/CT without capacity limitations: a Danish experience from a European perspective, Eur Radiol, 21, pp. 1277-1285, (2011)
[5]  
Basu S., Kwee T.C., Torigian D., Saboury B., Alavi A., Suboptimal and inadequate quantification: an alarming crisis in medical application of PET, Eur J Nucl Med Mol Imaging, 38, pp. 1381-1382, (2011)
[6]  
Basu S., Alavi A., Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should they be routinely employed in assessing patients with cancer?, Eur J Nucl Med Mol Imaging, 34, pp. 1527-1529, (2007)
[7]  
Basu S., Kwee T.C., Surti S., Akin E.A., Yoo D., Alavi A., Fundamentals of PET and PET/CT imaging, Ann N Y Acad Sci, 1228, pp. 1-18, (2011)
[8]  
Schillaci O., Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity, Semin Nucl Med, 42, pp. 267-280, (2012)
[9]  
Basu S., Zaidi H., Holm S., Alavi A., Quantitative techniques in PET-CT imaging, Curr Med Imaging Rev, 7, pp. 216-233, (2011)
[10]  
Kwee T.C., Torigian D.A., Alavi A., Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantification, J Thoracic Imaging, 28, pp. 4-10, (2013)